In February 2025, the FDA gave IND approval to United Therapeutics for the first xenotransplantation clinical trial, which followed a series of high-profile transplants via the compassionate use pathway from both United and rival eGenesis. Collectively, these milestones have created buzz around the potential for xenotransplantation to address the growing burden of End Stage Kidney […]
